This product is a second-generation sulfonylurea oral hypoglycemic drug. The main mechanism of its hypoglycemic effect is to stimulate pancreatic b cells to secrete insulin and partially increase the sensitivity of peripheral tissues to insulin. The speed of binding and dissociation of this product with insulin receptors is faster than that of glibenclamide, and it is less likely to cause severe hypoglycemia.

This product is a second-generation sulfonylurea oral hypoglycemic drug. Its main mechanism of hypoglycemic effect is to stimulate pancreatic b cells to secrete insulin and partially increase the sensitivity of peripheral tissues to insulin. This product binds to and dissociates from insulin receptors faster than glibenclamide and is less likely to cause severe hypoglycemia.

This product is a lipid-regulating drug of the clofibric acid derivative class. Its mechanism of action in lowering blood lipids is not yet fully understood. It may involve peripheral fat decomposition, reduce the liver's uptake of free fatty acids and reduce the formation of triglycerides in the liver, inhibit the synthesis of very low-density lipoprotein apolipoproteins and reduce the production of very low-density lipoproteins. This product reduces blood triglycerides and increases blood high-density lipoprotein concentrations. Although it can slightly reduce blood low-density lipoprotein cholesterol blood concentrations, it may increase low-density lipoprotein in type IV hyperlipoproteinemia. A 5-year placebo-controlled study showed that this product can reduce the occurrence of severe coronary heart disease sudden death and myocardial infarction. Long-term administration of 10 times the human dose to rats increased the incidence of liver malignancies and benign testicular tumors.

Vitamin B complex participates in the body's metabolism process. It is a necessary coenzyme for many metabolic links in the body and an important coenzyme for tissue respiration. Vitamin B1 is an important component of coenzymes required for carbohydrate metabolism. Vitamin B2 is an important coenzyme component required for tissue respiration. Vitamin B6 is a cofactor for many enzymes and participates in the metabolism of amino acids and fats. Nicotinamide is a component of coenzymes I and II, which is necessary for lipid metabolism, oxidation of tissue respiration and glycogenolysis. Sodium pantothenate is a precursor of coenzyme A and participates in the metabolism of carbohydrates, fats and proteins.

Important component of coenzymes required for carbohydrate metabolism

Important coenzyme component required for tissue respiration

A cofactor for many enzymes, involved in the metabolism of amino acids and fats

Component of coenzymes I and II, necessary for lipid metabolism, oxidation of tissue respiration, and glycogenolysis

Precursor of coenzyme A, involved in the metabolism of carbohydrates, fats, and proteins

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.